Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
about
Analysis of the lung microbiome in the "healthy" smoker and in COPDNetwork medicine analysis of COPD multimorbiditiesHereditary alpha-1-antitrypsin deficiency and its clinical consequencesCOPD exacerbation: lost in translationEfficacy and safety of indacaterol 150 microg once-daily in COPD: a double-blind, randomised, 12-week studyGlobal lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPDEpidemiology of chronic obstructive pulmonary disease: a literature review.Prevalence of airflow obstruction in U.S. adults aged 40-79 years: NHANES data 1988-1994 and 2007-2010A case-control study of airways obstruction among construction workersEstimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010Annual decline in forced expiratory volume is steeper in aluminum potroom workers than in workers without exposure to potroom fumesDefinition of COPD GOLD stage IStatins versus placebo for people with chronic obstructive pulmonary disease (COPD)Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at restNon-invasive ventilation during exercise training for people with chronic obstructive pulmonary diseaseBreathing exercises for chronic obstructive pulmonary diseaseCombined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary diseaseAirway clearance techniques for chronic obstructive pulmonary diseasePsychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary diseaseTai Chi for chronic obstructive pulmonary disease (COPD)Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary diseasePharmacological interventions for the treatment of anxiety and panic in chronic obstructive pulmonary diseaseNon-invasive ventilation during exercise training for people with chronic obstructive pulmonary diseaseGSTCD and INTS12 regulation and expression in the human lungLong-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysisβ(2) -adrenoceptor agonists: current and future directionGenes and chronic obstructive pulmonary diseaseValidation of chronic obstructive pulmonary disease (COPD) diagnoses in healthcare databases: a systematic review protocolStrategies for Management of the Early Chronic Obstructive Lung DiseaseAssociation between TNF-α -308 G/A polymorphism and COPD susceptibility: a meta-analysis updateYear in review 2015: Asthma and chronic obstructive pulmonary diseaseCOPD immunopathologyMeditative Movement as a Treatment for Pulmonary Dysfunction in Flight Attendants Exposed to Second-Hand Cigarette Smoke: Study Protocol for a Randomized Trial.The optimum timing to wean invasive ventilation for patients with AECOPD or COPD with pulmonary infectionCOPD: the patient perspectiveDiagnosis, assessment, and phenotyping of COPD: beyond FEV₁Strategies to improve anxiety and depression in patients with COPD: a mental health perspectiveThe Role of Innate and Adaptive Immune Cells in the Immunopathogenesis of Chronic Obstructive Pulmonary DiseaseAssociation between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysisAirway and Extracellular Matrix Mechanics in COPD
P2860
Q21091065-8409D004-5962-4C11-8CB0-160AA995909FQ21146673-FDF78E59-AB82-464E-934E-76EB0FC380A9Q21202920-CB83A850-9866-42E6-B0C6-234F067982B9Q21257182-E4B2D1F3-2D02-4AA7-BC8C-512FAD0C98ADQ21257191-28A1FECF-A0D8-4428-8CD3-D9174965466BQ22241773-4D695B66-742E-4590-9783-06BFD37C3473Q22305859-CC3B1363-9B8B-43D6-9601-6E90DC01EEB9Q23910517-F992D993-2384-4B6C-90DA-0C00B1D8EEE6Q23915116-46BCDA97-CDF8-438E-8126-7FFFA00457F4Q23922840-31B7260B-6655-447B-B953-0E1727D84469Q23923305-4A60519A-926F-4B79-B884-5EE6D66E5723Q23923340-5DB674ED-6DCA-4838-B864-38B7EECC5A20Q24188188-380000A4-1752-4B89-906B-CDD0AB874FDDQ24193787-01B91BC2-13F8-4B54-9E86-85AE17C61E64Q24194665-758497C5-EF4E-4355-84A5-BC2762139165Q24198776-4EFF3912-C443-484D-8AD1-DBE9C97A3F74Q24200446-8DE9A9EB-3294-4C4E-ABC4-E39571898480Q24201066-118B2400-7171-4410-8B97-276164E1B139Q24201469-081159DC-7F6D-4564-B4CB-2F29EA5DBB62Q24202338-900B07E8-937F-4D57-B86B-1C998D9D1778Q24235161-9D172501-03B3-4E80-8965-3E9AE9F52AA2Q24236047-12CA3E53-C874-45AC-96CF-1E13D1431A45Q24241953-1C7AC5AC-B1F5-4814-AB07-4931CE0FA3E1Q24337095-F47D9E00-8D51-46EA-B5B9-BCB2A34DE95FQ24597329-F54F3CFD-BDD7-47FD-9A67-ED1055015E3BQ24604047-F72911EA-D145-4ABC-8240-2EA385308079Q24630805-5EE4A970-E771-48CE-8115-21654F23F143Q24658536-A176A24B-512C-4CA4-A721-58AE44E3E008Q26739008-8A69CAB3-7565-4398-9A3E-948CFB506210Q26744358-D2288A03-E792-41A2-A41F-32914D1875E0Q26749314-A6BDBD77-D47A-4213-9F93-5C74F222F225Q26749575-071C75B4-4938-4B50-B4A6-585CD1DF3EC4Q26752376-DCEF20E8-79CE-4340-A9C4-1F678888EA12Q26752876-737E4166-FC05-4713-8A17-221F36D02E7DQ26764894-47295F57-C31B-41C1-B5D9-8387C894FDD2Q26764897-2E5B1E5C-2DFE-4951-8A2B-E3F257472A6BQ26765315-C82433C0-B4F1-42E5-9E22-FD3113D50E90Q26771902-47456D87-8D62-49F8-B196-9C481211F2E2Q26772143-C7AE2B6B-9FB8-4CC8-AC44-724040E1FC5FQ26773109-5774FE40-0B63-4B72-8105-821DA02BA42B
P2860
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@ast
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@en
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@en-gb
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@nl
type
label
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@ast
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@en
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@en-gb
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@nl
altLabel
Global strategy for the diagno ...... isease: GOLD executive summary
@en
prefLabel
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@ast
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@en
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@en-gb
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@nl
P2093
P3181
P1476
Global Strategy for the Diagno ...... Obstructive Pulmonary Disease
@en
P2093
Christine Jenkins
Jan Zielinski
Klaus F. Rabe
Peter Calverley
Peter J. Barnes
Roberto Rodriguez-Roisin
Sonia A. Buist
Suzanne Hurd
Yoshinosuke Fukuchi
P304
P3181
P356
10.1164/RCCM.200703-456SO
P407
P577
2007-09-15T00:00:00Z